Blood Separation Tubes Combine Serum Analysis with Plasma Analysis
|
By LabMedica International staff writers Posted on 09 Jul 2018 |
|
Image: The Vacuette Serum Fast Tubes, which offer a coagulation time of only five minutes (Photo courtesy of Greiner Bio-One).
A new line of blood separation tubes combines the quality of serum analysis with the speed of plasma analysis.
Greiner Bio-One (Kremsmünster, Austria) has released the Vacuette Serum Fast Tube, which with coagulation time of only five minutes enables serum to be analyzed as quickly as plasma.
The inside of the Vacuette tube wall is spray-coated with a Blood Clotting Activator (BCA)-thrombin additive mixture, which accelerates the coagulation process. With the Vacuette Serum Fast Tube, the total processing time is just 10 minutes (coagulation + centrifugation), compared to 40 minutes with conventional serum tubes, enabling easy and effective improvement of the turnaround time (TAT).
The tube also contains a gel that forms a stable barrier between the serum and the cellular components of the whole blood after centrifugation (five minutes at 3000 x g or 10 minutes at 1800 x g at 20 degrees Celsius).
To protect against contamination Vacuette Serum Fast Tubes are made of shatterproof PET (polyethylene terephthalate). They incorporate proven vacuum technology and have an easy-to-open safety cap. This promotes maintenance of hygienic working procedures without the risk of splatters, which can occur with standard rubber stoppers.
“Owing to the fast turnaround time, plasma tubes continue to be used for many analyses. However, determination of certain parameters on the basis of plasma is not appropriate for some tests,” said Dietmar Leichtfried, team leader research & development / preanalytics at Greiner Bio-One. "In some cases, incorrect values may result from the presence of anticoagulants or fibrinogen in the plasma tube. The use of serum is therefore indispensable in many cases."
Greiner Bio-One (Kremsmünster, Austria) has released the Vacuette Serum Fast Tube, which with coagulation time of only five minutes enables serum to be analyzed as quickly as plasma.
The inside of the Vacuette tube wall is spray-coated with a Blood Clotting Activator (BCA)-thrombin additive mixture, which accelerates the coagulation process. With the Vacuette Serum Fast Tube, the total processing time is just 10 minutes (coagulation + centrifugation), compared to 40 minutes with conventional serum tubes, enabling easy and effective improvement of the turnaround time (TAT).
The tube also contains a gel that forms a stable barrier between the serum and the cellular components of the whole blood after centrifugation (five minutes at 3000 x g or 10 minutes at 1800 x g at 20 degrees Celsius).
To protect against contamination Vacuette Serum Fast Tubes are made of shatterproof PET (polyethylene terephthalate). They incorporate proven vacuum technology and have an easy-to-open safety cap. This promotes maintenance of hygienic working procedures without the risk of splatters, which can occur with standard rubber stoppers.
“Owing to the fast turnaround time, plasma tubes continue to be used for many analyses. However, determination of certain parameters on the basis of plasma is not appropriate for some tests,” said Dietmar Leichtfried, team leader research & development / preanalytics at Greiner Bio-One. "In some cases, incorrect values may result from the presence of anticoagulants or fibrinogen in the plasma tube. The use of serum is therefore indispensable in many cases."
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read more
Molecular Diagnostics
view channel
Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more
Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more
Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
Human papilloma virus (HPV) is known to cause various cancers, including those of the genitals, anus, mouth, throat, and cervix. HPV-associated oropharyngeal cancer (HPV+OPSCC) is the most common HPV-associated... Read more
Hematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Microbiology
view channel
New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
According to the World Health Organization (WHO), an estimated 354 million individuals globally are afflicted with chronic hepatitis B or C. These viruses are the leading causes of liver cirrhosis, liver... Read more
1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more
.jpg "Image: Dr. Sam Lodge found that metabolic signatures can shift the speed of sepsis diagnosis (Photo courtesy of Murdoch University)")
Pathology
view channel
AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis
The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance
Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Industry
view channel
ECCMID Congress Name Changes to ESCMID Global
Over the last few years, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, Basel, Switzerland) has evolved remarkably. The society is now stronger and broader than ever before... Read more
Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
Given the presence of so many diseases, determining whether a patient is presenting the symptoms of a simple cold, the flu, or something as severe as life-threatening meningitis is usually only possible... Read more
Siemens to Close Fast Track Diagnostics Business
Siemens Healthineers (Erlangen, Germany) has announced its intention to close its Fast Track Diagnostics unit, a small collection of polymerase chain reaction (PCR) testing products that is part of the... Read more